Vasista Vittal 4
4 · REGENXBIO Inc. · Filed Aug 8, 2022
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Vasista Vittal
See Remarks
Transactions
- Sale
Common Stock
2022-08-04$35.00/sh−400$14,000→ 154,840 total - Sale
Common Stock
2022-08-05$35.19/sh−17,280$608,035→ 137,560 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $35.00 to $35.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.